Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Greenfield

Showing results (21-30 of 280) with videos related to

Pageof 28
Sort By:
Applied Optics|November 6, 2010
Optical parametric amplification of femtosecond pulses tunable from the blue to the infrared with microjoule energiesS R Greenfield, M R Wasielewski
Optics Letters|October 29, 2009
Near-transform-limited visible and near-IR femtosecond pulses from optical parametric amplification using Type II beta-barium borateS R Greenfield, M R Wasielewski
The Medical Journal of Australia|June 30, 2022
Sodium-glucose cotransporter 2 inhibitors in type 1 diabetes: a missed opportunity for cardiovascular protection?Jennifer R Snaith, Jerry R Greenfield
The Medical Journal of Australia|November 18, 2016
A review of maturity onset diabetes of the young (MODY) and challenges in the management of glucokinase-MODYRamy H Bishay, Jerry R Greenfield
Current Diabetes Reviews|January 29, 2008
Relationship between inflammation, insulin resistance and type 2 diabetes: 'cause or effect'?Jerry R Greenfield, Lesley V Campbell
Current Pharmaceutical Design|August 5, 2008
Role of the autonomic nervous system and neuropeptides in the development of obesity in humans: targets for therapy?Jerry R Greenfield, Lesley V Campbell
Diabetes|September 26, 2013
How sweet it is: intestinal sweet taste receptors in type 2 diabetesJerry R Greenfield, Donald J Chisholm
The New England Journal of Medicine|March 22, 2023
Once-Weekly Semaglutide in Adolescents with ObesityJennifer R Snaith, Jerry R Greenfield
Australian and New Zealand Journal of Medicine|September 14, 2000
Clinical trials and clinical practice--bridging the gaps in type 2 diabetes. An evidence-based approach to risk factor modification in type 2 diabetesJ R Greenfield, D J Chisholm
The Medical Journal of Australia|October 9, 2017
A review of maturity onset diabetes of the young (MODY) and challenges in the management of glucokinase-MODYRamy H Bishay, Jerry R Greenfield
Pageof 28

Showing results (21-30 of 280) with videos related to

Sort By:
Pageof 28
Applied Optics|November 6, 2010
Optical parametric amplification of femtosecond pulses tunable from the blue to the infrared with microjoule energiesS R Greenfield, M R Wasielewski
Optics Letters|October 29, 2009
Near-transform-limited visible and near-IR femtosecond pulses from optical parametric amplification using Type II beta-barium borateS R Greenfield, M R Wasielewski
The Medical Journal of Australia|June 30, 2022
Sodium-glucose cotransporter 2 inhibitors in type 1 diabetes: a missed opportunity for cardiovascular protection?Jennifer R Snaith, Jerry R Greenfield
The Medical Journal of Australia|November 18, 2016
A review of maturity onset diabetes of the young (MODY) and challenges in the management of glucokinase-MODYRamy H Bishay, Jerry R Greenfield
Current Diabetes Reviews|January 29, 2008
Relationship between inflammation, insulin resistance and type 2 diabetes: 'cause or effect'?Jerry R Greenfield, Lesley V Campbell
Current Pharmaceutical Design|August 5, 2008
Role of the autonomic nervous system and neuropeptides in the development of obesity in humans: targets for therapy?Jerry R Greenfield, Lesley V Campbell
Diabetes|September 26, 2013
How sweet it is: intestinal sweet taste receptors in type 2 diabetesJerry R Greenfield, Donald J Chisholm
The New England Journal of Medicine|March 22, 2023
Once-Weekly Semaglutide in Adolescents with ObesityJennifer R Snaith, Jerry R Greenfield
Australian and New Zealand Journal of Medicine|September 14, 2000
Clinical trials and clinical practice--bridging the gaps in type 2 diabetes. An evidence-based approach to risk factor modification in type 2 diabetesJ R Greenfield, D J Chisholm
The Medical Journal of Australia|October 9, 2017
A review of maturity onset diabetes of the young (MODY) and challenges in the management of glucokinase-MODYRamy H Bishay, Jerry R Greenfield
Pageof 28